Cipla to buy two US generic drug firms for $550 million

Last Updated: Friday, September 4, 2015, 10:53

Cipla Ltd said on Friday it has agreed to buy two generics businesses in the United States in an all-cash deals worth $550 million, as part of an effort to boost its presence in the world`s largest generics market.

Cipla shares end 5% lower on profit-booking

Last Updated: Monday, August 17, 2015, 22:58

Shares of drug major Cipla Monday pared early gains on profit-booking, falling 5 percent, even as the company reported an over two-fold jump in consolidated net profit for the quarter ended June 30, 2015.

Cipla to pay $26 mn upfront for 51% stake in Ugandan firm

Last Updated: Friday, July 24, 2015, 23:37

Drug major Cipla has re-negotiated payment terms for acquiring majority stake in Uganda's Quality Chemicals and now decided to pay USD 26 million (around Rs 166 crore) upfront to the shareholders of the African firm.

Lupin, Cipla bid for UCB's US generic drugs portfolio: Report

Last Updated: Monday, June 1, 2015, 18:56

Generic drugmakers Lupin Ltd and Cipla Ltdare among the companies bidding for top Belgian drugmaker UCB SA`s U.S. generic drugs business, a leading dailey reported on Monday, citing unnamed people with knowledge of the matter.

Cipla Q3 Net up 15% at Rs 328 cr; to buy 60% in Jay Precision

Last Updated: Thursday, February 12, 2015, 21:56

Pharmaceutical firm Cipla Ltd on Thursday reported 15.31 percent increase in its consolidated net profit at Rs 327.85 crore in the third quarter ended December 31, 2014.

Cipla bags Rs 1,100 crore order from South African govt

Last Updated: Tuesday, December 23, 2014, 18:04

Drug major Cipla's subsidiary has bagged an order worth 2 billion rand (around Rs 1,100 crore) for HIV drugs from the South African government.

Novartis sues India's Cipla over respiratory drug Onbrez

Last Updated: Wednesday, December 17, 2014, 19:21

Swiss drugmaker Novartis AG said on Wednesday it had sued India`s Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug`s price.

Cipla ups stake in Ugandan firm, acquires 14.5% for $15 million

Last Updated: Thursday, November 21, 2013, 15:17

Pharma firm Cipla Ltd on Thursday said it has gained majority stake in Uganda-based Quality Chemical Industries Ltd with the acquisition of additional 14.5 per cent stake for USD 15 million.

Morgan Stanley downgrades Cipla to "underweight"

Last Updated: Tuesday, August 13, 2013, 14:57

Morgan Stanley downgraded Cipla Ltd to "underweight" from "equal-weight" and reduces its target price on the stock to Rs 386 from Rs 414 citing slower growth prospects and valuations.

Drugs pricing row: HC extends relief to Cipla Ltd till Aug 27

Last Updated: Tuesday, July 30, 2013, 19:22

Delhi High Court on Tuesday extended the operation of its earlier order asking the Centre not to take coercive steps against pharma major Cipla Ltd which was told to replace stocks in the market with those carrying reduced prices within 45 days of new price notification.